Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Efalizumab for Moderate to Severe Atopic Dermatitis - A Phase I Pilot Study in Adults
Brief Summary: The purpose of this study is to determine if Raptiva will have beneficial effects in the treatment of patients with moderate to severe atopic dermatitis.